Thought Leadership
Blog | November 22, 2017
The Herceptin® Battle Moves into the District Court
Fish & Richardson
Read more
Blog | November 01, 2017
Read more
Alive and Well: The Doctrine of Equivalents in the U.S.
World Intellectual Property Review
Blog | October 24, 2017
Read more
Contingent Fee Litigation—A Low Risk Way to Enforce and Monetize Your Patents
Corporate Counsel
Blog | October 09, 2017
Mayo at Five: Are Traditional Method of Treatment Claims in Danger Under Section 101?
Fish & Richardson
Read more
Blog | October 05, 2017
Read more
Federal Circuit Faults PTO's Approach to Claim Amendments During IPR, But Allows PTO to Try to Fix the Problem
Fish & Richardson
Blog | September 28, 2017
Read more
The Unclear Scope Of 'All Patent Rights' In Patent Exhaustion
Law360
Blog | September 06, 2017
Mayo at Five: Eligibility of Diagnostic Method Claims
Fish & Richardson
Read more
Blog | September 05, 2017
Inadequacy of PTAB's Procedures for Reviewing Late-Submitted Evidence Leads to Vacatur
Fish & Richardson
Read more
Blog | August 02, 2017
PTAB Splits on Instituting Challenges to Herceptin® Patents
Fish & Richardson
Read more